CY1112428T1 - Θεραπειες για ασθενειες του κερατοειδους - Google Patents

Θεραπειες για ασθενειες του κερατοειδους

Info

Publication number
CY1112428T1
CY1112428T1 CY20111101183T CY111101183T CY1112428T1 CY 1112428 T1 CY1112428 T1 CY 1112428T1 CY 20111101183 T CY20111101183 T CY 20111101183T CY 111101183 T CY111101183 T CY 111101183T CY 1112428 T1 CY1112428 T1 CY 1112428T1
Authority
CY
Cyprus
Prior art keywords
treatments
coronary diseases
corneal disease
active ingredient
therapeutic agent
Prior art date
Application number
CY20111101183T
Other languages
English (en)
Inventor
Takahito Kimura
Shigeto Fujishita
Hiroyoshi Kawada
Original Assignee
Teika Pharmaceutical Co., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teika Pharmaceutical Co., Ltd filed Critical Teika Pharmaceutical Co., Ltd
Publication of CY1112428T1 publication Critical patent/CY1112428T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Παρέχεται θεραπευτικός παράγων για μια ασθένεια κερατοειδούς που περιλαμβάνει ozagrel ή άλας αυτού ως δραστικό συστατικό. Ο σκοπός είναι να βρεθεί μια ουσία ικανή ικανοποιητικώς να θεραπεύει/ανακουφίζει ασθένεια κερατοειδούς που έχει αυξηθεί στον αριθμό περιπτώσεων αυτών στα πρόσφατα έτη και να παρέχει θεραπευτικό παράγοντα για ασθένεια κερατοειδούς που περιλαμβάνει την ουσία ως δραστικό συστατικό.
CY20111101183T 2005-08-24 2011-11-30 Θεραπειες για ασθενειες του κερατοειδους CY1112428T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005242852 2005-08-24
EP06782954A EP1927353B1 (en) 2005-08-24 2006-08-24 Remedy for corneal diseases

Publications (1)

Publication Number Publication Date
CY1112428T1 true CY1112428T1 (el) 2015-12-09

Family

ID=37771620

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111101183T CY1112428T1 (el) 2005-08-24 2011-11-30 Θεραπειες για ασθενειες του κερατοειδους

Country Status (10)

Country Link
US (2) US20090247600A1 (el)
EP (1) EP1927353B1 (el)
JP (1) JP4778515B2 (el)
CY (1) CY1112428T1 (el)
DK (1) DK1927353T3 (el)
ES (1) ES2377342T3 (el)
PL (1) PL1927353T3 (el)
PT (1) PT1927353E (el)
SI (1) SI1927353T1 (el)
WO (1) WO2007023877A1 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4778262B2 (ja) * 2005-04-27 2011-09-21 テイカ製薬株式会社 角膜疾患治療剤
CN107405334B (zh) * 2015-03-23 2021-05-25 特一华制药株式会社 伴随干燥综合征的干眼症的治疗剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55313A (en) * 1978-06-13 1980-01-05 Kissei Pharmaceut Co Ltd Imidazole derivative
US5128326A (en) * 1984-12-06 1992-07-07 Biomatrix, Inc. Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
JP3453152B2 (ja) * 1992-04-06 2003-10-06 格 冨山 抗炎症点眼剤
EP1054003A4 (en) * 1998-02-05 2001-05-02 Senju Pharma Co UROCANIC ACID DERIVATIVES
JP4032179B2 (ja) * 2001-01-02 2008-01-16 アステラス製薬株式会社 一酸化窒素産生阻害活性を有するペプチド
JP4778262B2 (ja) 2005-04-27 2011-09-21 テイカ製薬株式会社 角膜疾患治療剤

Also Published As

Publication number Publication date
US20090247600A1 (en) 2009-10-01
WO2007023877A1 (ja) 2007-03-01
SI1927353T1 (sl) 2012-03-30
EP1927353A1 (en) 2008-06-04
PT1927353E (pt) 2012-02-07
US20100267665A1 (en) 2010-10-21
EP1927353B1 (en) 2011-11-23
ES2377342T3 (es) 2012-03-26
JPWO2007023877A1 (ja) 2009-02-26
DK1927353T3 (da) 2011-12-19
PL1927353T3 (pl) 2012-04-30
EP1927353A4 (en) 2010-03-31
US8318739B2 (en) 2012-11-27
JP4778515B2 (ja) 2011-09-21

Similar Documents

Publication Publication Date Title
BRPI0413427A (pt) derivados de piridilpirrol ativos como inibidores da cinase
BRPI0606473A2 (pt) suporte ósseo implantável tridimensional
CY2014023I1 (el) Συνδυασμοι και τροποι χορηγησης θεραπευτικων παραγοντων και θεραπεια συνδυασμου
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
DE602006006308D1 (de) Suspensionsformulierungen mit einem aktiven wirkstoff, einem poloxamer- oder meroxapol-tensid und einem glycol und ihre verwendung zur herstellung eines medikaments zur behandlung von augenkrankheiten
CL2011003346A1 (es) Compuestos derivados de 2,3-dihidro-5h-[1,3]tiazolo[3,2-a]pirimidin-5-ona, moduladores de pi3k; composicion farmaceutica; y uso para tratar una enfermedad de base inmunologica, cancer o enfermedad pulmonar en un paciente.
CY1109402T1 (el) Συνθεσεις για κολπικη χρηση
GT200800148A (es) Agente terapéutico para la enfermedad inflamatoria intestinal conteniendo como ingrediente activo un derivado de 2-amino-1,3-propanediol o un método para el tratamiento de la enfermedad inflamatoria intestinal.
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
BRPI0617077A2 (pt) Agente terapêutico para tratamento de doenças do fígado contendo 2-amina-1, 3-propanediol derivativo como ingrediente ativo, e método para tratamento de doenças do fígado
PA8748101A1 (es) Benzoxazoles y oxazolopiridinas que son utiles como inhibidores de las cinasas janus
PA8606201A1 (es) DERIVADOS DE PIRROLO[3,4-c) PIRAZOL ACTIVOS COMO INHIBIDORES DE QUINASA, PROCESO PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN
ATE453646T1 (de) 3-substituierte n-(aryl- oder heteroaryl)pyrazoä1,5-aüpyrimidine als kinaseinhibitoren
CY1110341T1 (el) Παραγωγα κιναζολινης και η χρηση τους στην θεραπευτικη αγωγη θρομβοκυτταραιμιας
AR054249A1 (es) Tratamiento de enfermedades del tejido conectivo de la piel
CY2018006I1 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
BRPI0413438A (pt) derivados de pirimidilpirrol ativos como inibidores de cinase
ATE541567T1 (de) Pharmazeutische zusammensetzung zur prävention und behandlung von metabolischen knochenerkrankungen mit alpha-arylmethoxyacrylat- derivaten
NO20064753L (no) Kombinasjonsterapi
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
CY1112428T1 (el) Θεραπειες για ασθενειες του κερατοειδους
EA200602002A1 (ru) Применение спинозинов для заживления ран
GB0522908D0 (en) Therapeutic agents
ITMI20021866A1 (it) Preparazione farmaceutica in forma colloidale utile nella cura delle affezioni cutanee.
PA8806001A1 (es) Nuevo uso medico de las sales de propionato de 3-(2,2,2-trimetilhidrazinio) en el tratamiento de la enfermedad cardíaca isquémica